玫瑰痤疮神经源性炎症及肉毒毒素治疗相关机制的研究进展

doi:10.35541/cjd.20200266

Abstract

Abstract: 【Abstract】 Localized neurovascular dysregulation is an important factor for the occurrence of rosacea, and it has been confirmed that neurogenic inflammation is a key step in neurovascular dysregulation. Intradermal injection of botulinum toxin can relieve facial flushing and burning sensations, which may be attributed to the inhibition of neuropeptide release from nerve endings and degranulation of mast cells. This review summarizes the research progress in neurogenic inflammation in the pathogenesis of rosacea and botulinum toxin in the treatment of rosacea, aiming to provide a basis for nerve-related basic research and clinical treatment of rosacea.

Key words: Rosacea, Neurogenic inflammation, Botulinum toxins

Liu Yixuan, Jiang Peiyu, Liu Yunyi, Zhang Jiawen, Tao Meng, Li Min, Xu Yang. Mechanism of neurogenic inflammation and botulinum toxin treatment in rosacea[J]. Chinese Journal of Dermatology, 2022, 55(6): 552-554.doi:10.35541/cjd.20200266

References ［30］

［1］	欧阳飞, 房慧, 曾慧, 等. 玫瑰痤疮的发病机制［J］. 临床医药文献电子杂志, 2020,7（20）:190,193.
［2］	孙菲菲, 林燕, 刘华绪，等.玫瑰痤疮难治性红斑治疗进展［J］. 中国麻风皮肤病杂志, 2020,36（9）:571⁃576. doi:10.12144/zgmfskin202009571.
［3］	Sousa⁃Valente J, Brain SD. A historical perspective on the role of sensory nerves in neurogenic inflammation［J］. Semin Immunopathol, 2018,40（3）:229⁃236. doi: 10.1007/s00281⁃018⁃0673⁃1.
［4］	邱晓, 华艳, 白玉龙. 神经源性炎症在复杂性区域疼痛综合征发病中的作用机制研究进展［J］. 中国临床神经科学, 2019,27（3）:329⁃334,346.
［5］	Choi JE, Di Nardo A. Skin neurogenic inflammation［J］. Semin Immunopathol, 2018,40（3）:249⁃259. doi: 10.1007/s00281⁃018⁃0675⁃z.
［6］	Kruger L, Perl ER, Sedivec MJ. Fine structure of myelinated mechanical nociceptor endings in cat hairy skin［J］. J Comp Neurol, 1981,198（1）:137⁃154. doi: 10.1002/cne.901980112.
［7］	McArthur JC, Stocks EA, Hauer P, et al. Epidermal nerve fiber density: normative reference range and diagnostic efficiency［J］. Arch Neurol, 1998,55（12）:1513⁃1520. doi: 10.1001/archneur.55. 12.1513.
［8］	Huet F, Misery L. Sensitive skin is a neuropathic disorder［J］. Exp Dermatol, 2019,28（12）:1470⁃1473. doi: 10.1111/exd.13991.
［9］	Sulk M, Seeliger S, Aubert J, et al. Distribution and expression of non⁃neuronal transient receptor potential （TRPV） ion channels in rosacea［J］. J Invest Dermatol, 2012,132（4）:1253⁃1262. doi: 10.1038/jid.2011.424.
［10］	Schwab VD, Sulk M, Seeliger S, et al. Neurovascular and neuroimmune aspects in the pathophysiology of rosacea［J］. J Investig Dermatol Symp Proc, 2011,15（1）:53⁃62. doi: 10.1038/jidsymp.2011.6.
［11］	Lonne⁃Rahm S, Nordlind K, Edström DW, et al. Laser treatment of rosacea: a pathoetiological study［J］. Arch Dermatol, 2004,140（11）:1345⁃1349. doi: 10.1001/archderm.140.11.1345.
［12］	张华雄, 李吉. 玫瑰痤疮先天免疫及周围神经相关致病机理研究进展［J］. 医学信息, 2019,32（8）:53⁃57. doi: 10.3969/j.issn.1006⁃1959.2019.08.017.
［13］	Aubdool AA, Brain SD. Neurovascular aspects of skin neurogenic inflammation［J］. J Investig Dermatol Symp Proc, 2011,15（1）:33⁃39. doi: 10.1038/jidsymp.2011.8.
［14］	Russell FA, King R, Smillie SJ, et al. Calcitonin gene⁃related peptide: physiology and pathophysiology［J］. Physiol Rev, 2014,94（4）:1099⁃1142. doi: 10.1152/physrev.00034.2013.
［15］	Helfrich YR, Maier LE, Cui Y, et al. Clinical, histologic, and molecular analysis of differences between erythematotelangiectatic rosacea and telangiectatic photoaging［J］. JAMA Dermatol, 2015,151（8）:825⁃836. doi: 10.1001/jamadermatol.2014.4728.
［16］	Baylie RL, Brayden JE. TRPV channels and vascular function［J］. Acta Physiol （Oxf）, 2011,203（1）:99⁃116. doi: 10.1111/j.1748⁃1716.2010.02217.x.
［17］	Samanta A, Hughes T, Moiseenkova⁃Bell VY. Transient receptor potential （TRP） channels［J］. Subcell Biochem, 2018,87:141⁃165. doi: 10.1007/978⁃981⁃10⁃7757⁃9_6.
［18］	王莲, 张自辉, 蒋献. 玫瑰痤疮发病机制的研究进展［J］. 实用皮肤病学杂志, 2019,12（3）:171⁃174. doi: 10.11786/sypfbxzz. 1674⁃1293.20190312.
［19］	Moore C, Cevikbas F, Pasolli HA, et al. UVB radiation generates sunburn pain and affects skin by activating epidermal TRPV4 ion channels and triggering endothelin⁃1 signaling［J］. Proc Natl Acad Sci U S A, 2013,110（34）:E3225⁃3234. doi: 10. 1073/pnas.1312933110.
［20］	陈晓曦. 肥大细胞特异性受体介导神经源性炎症和疼痛［J］. 中国疼痛医学杂志, 2019,25（3）:171. doi: 10.3969/j.issn.1006⁃9852.2019.03.006.
［21］	Muto Y, Wang Z, Vanderberghe M, et al. Mast cells are key mediators of cathelicidin⁃initiated skin inflammation in rosacea［J］. J Invest Dermatol, 2014,134（11）:2728⁃2736. doi: 10.1038/jid.2014.222.
［22］	Mascarenhas NL, Wang Z, Chang YL, et al. TRPV4 mediates mast cell activation in cathelicidin⁃induced rosacea inflammation［J］. J Invest Dermatol, 2017,137（4）:972⁃975. doi: 10.1016/j.jid.2016.10.046.
［23］	李明凤, 蒋娟. 玫瑰痤疮发病的免疫机制研究进展［J］. 中国麻风皮肤病杂志, 2017,33（11）:690⁃692,697.
［24］	Dayan SH, Pritzker RN, Arkins JP. A new treatment regimen for rosacea: onabotulinumtoxinA［J］. J Drugs Dermatol, 2012,11（12）:e76⁃e79.
［25］	Bharti J, Sonthalia S, Jakhar D. Mesotherapy with botulinum toxin for the treatment of refractory vascular and papulopustular rosacea［J］. J Am Acad Dermatol, 2018,S0190⁃9622（18）30808⁃9. doi: 10. 1016/j.jaad.2018. 05.014.
［26］	Kim MJ, Kim JH, Cheon HI, et al. Assessment of skin physiology change and safety after intradermal injections with botulinum toxin: a randomized, double⁃blind, placebo⁃controlled, split⁃face pilot study in rosacea patients with facial erythema［J］. Dermatol Surg, 2019,45（9）:1155⁃1162. doi: 10.1097/DSS.000000 000000 1819.
［27］	Park KY, Hyun MY, Jeong SY, et al. Botulinum toxin for the treatment of refractory erythema and flushing of rosacea［J］. Dermatology, 2015, 230（4）:299⁃301. doi: 10.1159/000368773.
［28］	黄智, 连亚军, 武守义. 肉毒毒素抗癫痫作用的研究进展［J］. 中国实用神经疾病杂志, 2018,21（3）:336⁃339. doi: 10.12083/SYSJ.2018.03.086.
［29］	Choi JE,Werbel T, Wang Z, et al. Botulinum toxin blocks mast cells and prevents rosacea like inflammation. J Dermatol Sci, 2019,93（1）:58⁃64. doi: 10.1016/j.jdermsci.2018.12.004.
［30］	Ramachandran R, Marino MJ, Paul S, et al. A study and review of effects of botulinum toxins on mast cell dependent and independent pruritus［J］. Toxins （Basel）, 2018,10（4）:134. doi: 10.3390/toxins10040134.

[1]	Song Xiaoting, Liu Bo, Chen Yudi, Zhao Zuotao. Pathophysiological pathogenesis of rosacea [J]. Chinese Journal of Dermatology, 2022, 55(5): 446-449.
[2]	Wang Xiaoyan, Zhang Jiawen, Liu Yunyi, Liu Yixuan, Jiang Peiyu, Li Min, Meng Tao, Xu Yang. Skin imaging and noninvasive measurements of rosacea [J]. Chinese Journal of Dermatology, 2022, 0(1): 20200939-e20200939.
[3]	Deng Qing, Liu Fangfen, Shi Wei, Xie Hongfu, Li Ji, Huang Yingxue. Willingness to pay for treatment of rosacea and its influencing factors： a survey of patients in Changsha region [J]. Chinese Journal of Dermatology, 2021, 54(4): 352-355.
[4]	Li Jian, Song Zhiqiang. New insights into facial flushing and erythema in rosacea [J]. Chinese Journal of Dermatology, 2021, 54(4): 360-363.
[5]	Rosacea Research Center, Chinese Society of Dermatology, Rosacea Professional Committee, Chinese Dermatologist Association. Guidelines for the diagnosis and treatment of rosacea in China （2021 edition） [J]. Chinese Journal of Dermatology, 2021, 54(4): 279-288.
[6]	Zhang Erjia, Lin Tong. Efficacy of two kinds of intense pulsed light for the treatment of rosacea [J]. Chinese Journal of Dermatology, 2021, 54(3): 207-211.
[7]	Li Yueyue, Luo Dan. Roles and action mechanisms of skin microbiota in the occurrence of rosacea [J]. Chinese Journal of Dermatology, 2021, 54(12): 1122-1125.
[8]	Li Rong, Zhang Jiaan, Chen Kun. Photoelectric therapy for rosacea [J]. Chinese Journal of Dermatology, 2021, 0(1): 20201002-e20201002.
[9]	Tao Meng, Li Min, Liu Yixuan, Liu Yunyi, Jiang Peiyu, Zhang Jiawen, Nan Yuqin, Xu Yang. Correlation between rosacea and neuropsychiatric diseases [J]. Chinese Journal of Dermatology, 2021, 0(1): 20201083-e20201083.
[10]	Wang Yaling, Xie Hongfu, Li Ji, Wang Ben. JAK-STAT signaling pathway and rosacea [J]. Chinese Journal of Dermatology, 2021, 0(1): 20200592-e20200592.
[11]	Wang Ben, Zhao Zhixiang, Jian Dan, Shi Wei, Liu Fangfen, Liu Hui, Yu Bin, Xia Jianxin, Yang Jie, Wu Lin, Ju Qiang, Li Ji, Xie Hongfu. Analysis of clinical features of rosacea and rediscussion of a Chinese diagnostic criterion for rosacea [J]. Chinese Journal of Dermatology, 2020, 53(9): 675-679.
[12]	Zhong Caimei, He Sihua, Zhao Weifeng, Zhong Jianneng, Zhou Meifeng, Deng Yuhua. Effect of nasal parasitism by Demodex mites on nasal skin microbiome in patients with rosacea [J]. Chinese Journal of Dermatology, 2020, 53(5): 345-351.
[13]	Shi Qi, Zhao Zhixiang, Xie Hongfu, Li Ji, Wang Ben. Analysis of clinical features of intermittent flushing in patients with rosacea and its impact on quality of life [J]. Chinese Journal of Dermatology, 2020, 53(5): 340-344.
[14]	Tang Jia, Shi Ying, Zhou Junfeng, Chen Yao, Li Shanshan. Two cases of familial benign pemphigus treated with botulinum toxin type A [J]. Chinese Journal of Dermatology, 2020, 53(5): 368-370.
[15]	Li Feng, Zheng Xiaofeng, Qiao Ju, Liu Jie, Jin Hongzhong. Evaluation of botulinum toxin A injections for the treatment of glabellar lines by using high-frequency ultrasound [J]. Chinese Journal of Dermatology, 2020, 53(3): 223-225.

Mechanism of neurogenic inflammation and botulinum toxin treatment in rosacea

PDF

PDF (Mobile)

Knowledge

Abstract

Cite this article

share this article

References ［30］

Related Articles 15

Metrics

Comments

Recommended 10